Fatma Duygu KAYA YERTUTANOL

Doç.Dr. Fatma Duygu KAYA YERTUTANOL

Psychiatry Specialist

Born in 1981 in Istanbul, he graduated from TED Ankara College Foundation Private High School in 1999. In 2005, he graduated from Gazi University Faculty of Medicine. He started his Psychiatry Specialization training at Gazi University Faculty of Medicine, Department of Psychiatry and received the title of Psychiatry Specialist in 2010. Afterwards, he started to work as a specialist physician at Ankara Elmadağ State Hospital to complete his State Service Obligation. In the same year, he started his PhD in the Neuroscience PhD Program at Gazi University Neuropsychiatry Center. He left Elmadağ State Hospital at the end of 2014 at his own request.

In 2007, after receiving the Certificate of Using Experimental Animals from Gazi University Laboratory Animal Breeding and Experimental Research Center, she started to conduct animal experiments. She took part in a BAP project and studies in which psychiatric diseases were modeled in rodents and behavioral analysis and immunohistochemical evaluation of changes in the nervous system with psychopharmacological agents or behavioral interventions were performed. In 2017, he completed his PhD in Neuroscience, which he started in 2010, with his thesis on "Behavioral Effects of Gabapentin on Schizophrenia-Like Picture to be Created by Sleep Deprivation in Rats" and received the title of doctor of science.

In addition to his articles published in local and foreign journals, he has two book chapters, one national and one international. He has made scientific speeches at numerous congresses, conferences and symposiums. He has one national and one international poster award. He has completed two TUBITAK-3001 Projects, one of which he was the executive director and one of which he was a researcher. His scientific interests include schizophrenia and other psychotic disorders, addiction, psychopharmacology, psychiatric disease modeling in experimental animals and neurophilosophy.

He is a member of the Turkish Medical Association, a member of the Psychiatric Association of Turkey and a member of the Board of Directors of NPFUAM (Neuropsychopharmacology Application and Research Center). He is a member of the Neuroscience Section and Psychopharmacology and Somatic Treatments Section of the Psychiatric Association of Turkey. Since 2010, he has been a member of the Editorial Board of the Journal of Clinical Psychiatry and since 2015 he has been a member of the Editorial Board of The Journal of Neurobehavioral Sciences. He speaks English fluently and is married.

Our Doctors